Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
4.
Parasitol Res ; 119(1): 267-281, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31760500

ABSTRACT

Coccidia (Chromista: Miozoa: Eimeriidae) of columbiform birds (Aves: Columbiformes) have been described since the end of the nineteenth century; however, some of these descriptions were poorly detailed or inconclusive. In this sense, the current work makes a detailed taxonomic revision reconsidering and organizing 18 Eimeria spp. and two Isospora spp. previously described or reported of Columbiformes. Along with this, a new species of Eimeria is morphologically and molecularly identified by the mitochondrial cytochrome c oxidase subunit 1 (COI) gene and by the 18S small subunit ribosomal RNA (18S) gene from the ruddy ground-dove Columbina talpacoti (Temminck, 1809) in the Médio Paraíba region of the State of Rio de Janeiro, southeastern Brazil. Eimeria columbinae n. sp. has subspheroidal oocysts, 14.7 × 13.2 µm, with smooth, bi-layered wall, ~ 1.1 µm and length/width ratio of 1.1. Micropyle and oocyst residuum are present, but polar granule is absent. Sporocysts are ellipsoidal to slightly asymmetrical, 9.0 × 5.1 µm, with both Stieda and sub-Stieda bodies. Sporocyst residuum present and sporozoites with refractile body and nucleus. This is the 19th description of an eimerian from Columbiformes in the World, and the second to have a molecular identification of the COI and 18S genes.


Subject(s)
Bird Diseases/parasitology , Coccidiosis/veterinary , Columbiformes/parasitology , Eimeriidae/classification , Animals , Bird Diseases/epidemiology , Brazil/epidemiology , Coccidiosis/epidemiology , Coccidiosis/parasitology , Cyclooxygenase 1/genetics , Eimeriidae/cytology , Eimeriidae/genetics , Eimeriidae/isolation & purification , Oocysts/cytology , Oocysts/isolation & purification , Protozoan Proteins/genetics , RNA, Ribosomal, 18S/genetics , Sporozoites/cytology , Sporozoites/isolation & purification
6.
Nanoscale ; 11(34): 16130-16141, 2019 Aug 29.
Article in English | MEDLINE | ID: mdl-31432842

ABSTRACT

The introduction of dopant atoms into metal nanoparticles is an effective way to control the interaction with adsorbate molecules and is important in many catalytic processes. In this work, experimental and theoretical evidence of the influence of Pd doping on the bonding between small cationic AuN+ clusters and CO is presented. The CO adsorption is studied by combining low-pressure collision cell reactivity and infrared multiple photon dissociation spectroscopy experiments with density functional theory calculations. Measured dissociation rates of cluster-CO complexes (N ≤ 21) allow the estimation of cluster-CO binding energies, showing that Pd doping increases the CO adsorption energy to an extent that is size-dependent. These trends are reproduced by theoretical calculations up to N = 13. In agreement with theory, measurements of the C-O vibrational frequency suggest that for the doped PdAuN-1+ (N = 3-5, 11) clusters, CO adsorbs on an Au atom, while for N = 6-10 and N = 12-14, CO interacts directly with the Pd dopant. A pronounced red-shifting of the C-O vibrational frequency is observed when CO interacts directly with the Pd dopant, indicating a significant back-donation of electron charge from Pd to CO. In contrast, the blue-shifted frequencies, observed when CO interacts with an Au atom, indicate that σ-donation dominates the Au-CO interaction. Studying such systems at the sub-nanometre scale enables a fundamental comprehension of the interactions between adsorbates, dopants and the host (Au) species at the atomic level.

7.
Saúde Redes ; 4(2): 191-217, abr.- jun. 2018.
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1022958

ABSTRACT

O artigo estuda as mudanças feitas na Política Nacional de Atenção Básica em 2017 dando foco àquelas com maior efeito imediato na ação dos gestores municipais, como as alterações relacionadas aos agentes comunitários de saúde, regras das equipes de saúde da família, criação de incentivo para equipe não saúde da família, proposição dos padrões essencial e avançado para a atenção básica e os efeitos da mudança no financiamento federal da atenção básica. Para isso, utiliza o referencial teórico do campo de análise de políticas e, como método, faz uma revisão de literatura e análise documental de textos legais e oficiais e publicações da posição e justificativas dos principais formuladores da política além de algumas instituições e organizações que se colocaram contra. A análise aponta que a política elegeu instrumentos que se apresentaram insuficientes e fragiliza aqueles que mostraram ter efeito, desestimula a estratégia de saúde da família e estimula equipes que a literatura e avaliações oficiais mostraram ter piores resultados. Conclui as mudanças na PNAB-2017 não conseguem ser explicadas com base no discurso técnico- cientifico na medida em que atua contra as evidências e estudos disponíveis. Seu sentido latente é encontrado no papel que cumpre na agenda e política mais macro do país, formulada e levada a cabo no sistema político e voltada para o ajuste fiscal neoliberal, e conforme a correlação de forças e interesses específicos dos atores do subsistema de saúde.


The article studies the changes made in the National Primary Health Care Policy in 2017, focusing on those with greater immediate effect on the actions of municipal managers, such as changes related to community health agents, rules of family health teams, creation of incentive for non-family health team, proposing the essential and advanced standards for primary health care and the effects of the change in federal funding of prymary health care. To do so, it uses the theoretical framework of the policy analysis and, as a method, reviews the literature and documentary analysis of legal and official texts and publications of the position and justifications of the main policy makers, as well as some institutions and organizations that against. The analysis points that the policy chose policy instruments that were insufficient and weakens those that showed effect, discourages the family health strategy and stimulates teams that the literature and official evaluations have shown worse results. Concludes the changes in PNAB- 2017 can not be explained based on the technical- scientific discourse in that it acts against the available evidence and studies. Its latent meaning is found in the role it fulfills in the macro agenda and macro policy of the country, formulated and carried out in the political system and focused on neoliberal fiscal adjustment, and according to the correlation of specific forces and interests of the subsystem health actors.

8.
Phys Chem Chem Phys ; 19(39): 27090-27098, 2017 Oct 11.
Article in English | MEDLINE | ID: mdl-28960217

ABSTRACT

The structures and surface adsorption sites of Pd-Ir nanoalloys are crucial to the understanding of their catalytic performance because they can affect the activity and selectivity of nanocatalysts. In this article, density functional theory (DFT) calculations are performed on bare Pd-Ir nanoalloys to systematically explore their stability and chemical ordering properties, before studying the adsorption of CO on the nanoalloys. First, the structural stability of 38-atom and 79-atom truncated octahedral (TO) Pd-Ir nanoalloys are investigated. Then the adsorption properties and preferred adsorption sites of CO on 38-atom Pd-Ir nanoalloys are considered. The PdshellIrcore structure, which has the lowest energy of all the considered isomers, exhibits the highest structural stability, while the PdcoreIrshell configuration is the least stable. In addition, the adsorption strength of CO on Ir atoms is found to be greater than on Pd for Pd-Ir nanoclusters. The preferred adsorption sites of CO on pure Pd and Ir clusters are in agreement with calculations and experiments on extended Pd and Ir surfaces. In addition, d-band center and charge effects on CO adsorption strength on Pd-Ir nanoalloys are analyzed by comparison with pure clusters. The study provides a valuable theoretical insight into catalytically active Pd-Ir nanoalloys.

9.
Phys Chem Chem Phys ; 18(37): 26133-26143, 2016 Sep 21.
Article in English | MEDLINE | ID: mdl-27711424

ABSTRACT

The Birmingham Parallel Genetic Algorithm (BPGA) has been adopted for the global optimization of free and MgO(100)-supported Pd, Au and AuPd nanocluster structures, over the size range N = 4-10. Structures were evaluated directly using density functional theory, which has allowed the identification of Pd, Au and AuPd global minima. The energetics, structures, and tendency of segregation have been evaluated by different stability criteria such as binding energy, excess energy, second difference in energy, and adsorption energy. The ability of the approach in searching for putative global minimum has been assessed against a systematic homotop search method, which shows a high degree of success.

10.
Clin Drug Investig ; 24(10): 611-8, 2004.
Article in English | MEDLINE | ID: mdl-17523723

ABSTRACT

BACKGROUND AND OBJECTIVE: Bendamustine is an alkylating agent with high efficacy in non-Hodgkin's lymphoma and multiple myeloma. Even in solid tumours, monotherapy with bendamustine has resulted in subjective remissions and has been associated with a low rate of side effects. The current dose-finding study was designed to determine the maximum tolerated dose (MTD) of combined carboplatin/bendamustine in previously untreated patients with extensive-stage small cell lung cancer (SCLC). PATIENTS AND METHODS: Carboplatin was administered as a 1-hour infusion on day 1 at increasing dose levels, and bendamustine was administered as a short infusion on days 1 and 2 at increasing dose levels (80-120 mg/m(2)). The regimen was administered every 3 weeks. Four dose levels were planned, starting with 80 mg/m(2) bendamustine and carboplatin area under the curve (AUC) 5 (dose level I). The other dose levels were 100 mg/m(2) bendamustine and carboplatin AUC 5 (dose level II), 100 mg/m(2) bendamustine and carboplatin AUC 6 (dose level III), and 120 mg/m(2) bendamustine and carboplatin AUC 6 (dose level IV). A minimum of three patients were enrolled at each dose level. RESULTS: Dose-limiting toxicities, which included fatigue, infection and tachyarrhythmia, were observed at dose level III. The recommended dose for phase II studies was therefore established at dose level II. The majority of haematological and non-haematological toxicities observed were only mild (grade 1 or 2) in patients at dose levels I and II. None of the patients developed severe alopecia. Objective responses were observed in eight of the ten patients involved in this trial. CONCLUSION: Because of its acceptable toxicity and favourable preliminary antitumour efficacy, the combination of carboplatin and bendamustine appears to be a potentially useful chemotherapeutic option in patients with extensive SCLC.

11.
Int Arch Occup Environ Health ; 76(2): 143-50, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12733087

ABSTRACT

OBJECTIVE: Orthostatic intolerance (OI) is a syndrome that is characterised by headache, concentration difficulties, palpitation of the heart, dizziness associated with postural tachycardia and plasma norepinephrine concentrations that are disproportionately high when the sufferer is in the upright posture. In contrast to other forms of orthostatic dysregulation - orthostatic hypotension (OH) and postural orthostatic tachycardia syndrome (POTS) - OI, hitherto, could be diagnosed only by a tilt table examination, with high expenditure. In this paper we examine the reliability and validity of a questionnaire as a screening instrument for OI. METHODS: We studied 138 young men (mean age 21.6 years) who were undergoing military service. After a medical check and filling in the questionnaire, the participants underwent a tilt table test including monitoring of blood pressure, heart rate and plasma catecholamines, in the supine position and during 30 min of standing. The questionnaire consisted of ten items registering presence and frequency of typical OI symptoms. RESULTS: Probands (104) showed normal tilt table test results. OI was diagnosed in 14 probands, OH in 6 and POTS in 14. The OI participants scored significantly higher in the questionnaire than the healthy subjects did: the mean score of the OI group was 22.6, the healthy participants had a mean score of 3.9. Participants with POTS had a mean score of 13.5 and subjects with OH had a mean score of 17.0. Reliability analysis showed a Cronbach's alpha of 0.888. Validity analysis showed that 93.5% of the probands with any kind of orthostatic dysregulation can be detected. CONCLUSIONS: We were able to establish a short questionnaire as a reliable and valid screening instrument for OI. Usage of this questionnaire can simplify enormously the diagnostic management of patients with suspected OI.


Subject(s)
Hypotension, Orthostatic/diagnosis , Occupational Diseases/diagnosis , Surveys and Questionnaires , Adolescent , Adult , Catecholamines/blood , Humans , Hypotension, Orthostatic/etiology , Hypotension, Orthostatic/physiopathology , Male , Military Personnel , Occupational Diseases/etiology , Occupational Diseases/physiopathology , Reproducibility of Results , Tilt-Table Test , Workplace
12.
Anticancer Drugs ; 12(9): 725-9, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11593053

ABSTRACT

Low-grade non-Hodgkin's lymphomas (NHL) are very sensitive to a broad range of chemotherapeutic and biological agents. Relapses, however, occur even after aggressive cytostatic combinations in first-line therapy. Therefore, effective and well-tolerated salvage therapies are very important. In this single-institution trial, the efficacy and toxicity of bendamustine in the treatment of relapsed low-grade NHL was investigated. Fifty-eight patients with low-grade NHL pretreated with different cytostatic regimens were included. All patients received bendamustine at 120 mg/m(2) as a 1-h infusion on 2 consecutive days. The treatment was repeated every 3 weeks until complete remission (CR), partial remission (PR) or stable disease (SD) was confirmed on two consecutive cycles. Efficacy and toxicity were evaluated in 52 patients: CR was induced in 11%, PR in 62% and SD in another 10% of the patients. No response to treatment was seen in 17%. The median duration of remission was 16 months and the median survival time was 36 months. Side effects were generally mild, and restricted to myelosuppression, gastrointestinal toxicity and allergic reactions. Bendamustine proved to be very effective and was well tolerated in pretreated patients with relapsed or primary resistant low-grade NHL.


Subject(s)
Antineoplastic Agents/therapeutic use , Lymphoma, Non-Hodgkin/drug therapy , Neoplasm Recurrence, Local/drug therapy , Nitrogen Mustard Compounds/therapeutic use , Adult , Aged , Bendamustine Hydrochloride , Female , Humans , Male , Middle Aged , Remission Induction , Survival Analysis
13.
Obstet Gynecol Surv ; 54(8): 526-31, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10434273

ABSTRACT

UNLABELLED: Peripartum cardiomyopathy (PPCM) is a poorly characterized, rare form of cardiomyopathy. The etiology of PPCM is unknown, but viral, autoimmune, and idiopathic causes may contribute. The presentation is similar to other forms of congestive heart failure; the diagnosis of PPCM should not be considered until other causes of cardiac dysfunction are ruled out. Echocardiography is central to diagnosis. Early diagnosis and initiation of treatment are essential to optimize pregnancy outcome. Intensivists and anesthesiologists should be consulted to assist with management in complicated cases. Management of PPCM is essentially supportive. Prognosis is poor, although cardiac transplant is improving prognosis and should be considered when conventional therapy fails. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians LEARNING OBJECTIVES: After completion of this article, the reader will be able to understand the typical presentation of peripartum cardiomyopathy including adverse outcome predictors, to understand how to make the diagnosis of PPCM and how to manage it, and to understand the natural history of the disease.


Subject(s)
Cardiomyopathy, Dilated , Pregnancy Complications, Cardiovascular , Puerperal Disorders , Cardiomyopathy, Dilated/diagnosis , Cardiomyopathy, Dilated/etiology , Cardiomyopathy, Dilated/therapy , Cardiotonic Agents/therapeutic use , Diagnosis, Differential , Female , Heart Transplantation , Humans , Pregnancy , Pregnancy Complications, Cardiovascular/diagnosis , Pregnancy Complications, Cardiovascular/etiology , Pregnancy Complications, Cardiovascular/therapy , Prognosis , Puerperal Disorders/diagnosis , Puerperal Disorders/etiology , Puerperal Disorders/therapy , Recurrence , Risk Factors , Ventricular Function, Left/physiology
14.
J Med Virol ; 58(3): 313-20, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10447429

ABSTRACT

Sequence analysis of 285 nucleotides located on the variable part of the N gene was undertaken on measles virus (MV) samples collected from acutely infected patients in Germany, the Czech Republic, Denmark, Poland, and Russia. Two distinct genotypes (C2 and D6) have circulated in Germany between 1993 and 1996. Isolates of genotype C2 were related to strains reported in Germany before 1993. This genotype was also found in the Czech Republic in 1992 and in Denmark in 1997. The occurrence of genotype D6 in Germany is described below for the first time. In 1998, this genotype was identified in Poland. Genotypes C2 and D6 were also reported in Spain and in the United Kingdom between 1992 and 1996. Therefore, it is concluded that these genotypes are widely distributed over Europe. The analysis of the isolates from Russia revealed that genotype A was present in 1988 in the European part of the country and in 1996 in Siberia. An isolate identified in 1997 in Siberia belonged to genotype D6, which had never been found previously in Russia. We also analysed MV obtained from a case of subacute sclerosing panencephalitis (SSPE) in 1995 in Turkey. A comparison of this sequence with published sequences implied that this SSPE case was associated with a new genetic lineage of MV.


Subject(s)
Measles virus/genetics , Measles virus/isolation & purification , Base Sequence , DNA, Complementary/chemistry , DNA, Complementary/genetics , Europe , Genotype , Humans , Measles virus/classification , Molecular Sequence Data , Phylogeny , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Russia , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid , Serotyping
15.
Am J Perinatol ; 16(2): 89-92, 1999.
Article in English | MEDLINE | ID: mdl-10355916

ABSTRACT

Sacrococcygeal teratoma is the most common fetal neoplasm, with an incidence of 1 in 40,000 births. Fetuses with this malformation are at risk for significant perinatal morbidity and mortality. We identified nine fetuses with sacrococcygeal teratomas that were diagnosed antenatally and managed at the University of North Carolina Hospitals over a 7-year period. We retrospectively reviewed the charts of mothers and infants and recorded data concerning perinatal and surgical management. Six infants survived the neonatal period. All infants diagnosed after 20 weeks' gestation survived. Fetal hydrops developed in three fetuses, all of whom died. Inadequate ventilation secondary to prematurity was a contributing factor in each lethal case. Diagnosis at an early gestational age, development of fetal hydrops, and premature delivery predicted a poor prognosis. When possible, we recommend that delivery be delayed to allow for fetal development. Stabilization of the infant should be attempted before resection of the teratoma.


Subject(s)
Fetal Diseases/diagnostic imaging , Spinal Neoplasms/diagnostic imaging , Teratoma/diagnostic imaging , Ultrasonography, Prenatal , Female , Fetal Diseases/therapy , Follow-Up Studies , Humans , Hydrops Fetalis/etiology , Infant, Newborn , Male , Pregnancy , Retrospective Studies , Sacrococcygeal Region , Spinal Neoplasms/congenital , Spinal Neoplasms/mortality , Spinal Neoplasms/surgery , Teratoma/congenital , Teratoma/mortality , Teratoma/surgery
16.
Am J Perinatol ; 16(1): 47-50, 1999.
Article in English | MEDLINE | ID: mdl-10362082

ABSTRACT

Sacrococcygeal teratoma is the most common fetal neoplasm, with an incidence of 1 in 40,000 births. Fetuses with this malformation are at risk for significant perinatal morbidity and mortality. We identified nine fetuses with sacrococcygeal teratomas that were diagnosed antenatally and managed at the University of North Carolina Hospitals over a 7-year period. We retrospectively reviewed the charts of mothers and infants and recorded data concerning perinatal and surgical management. Six infants survived the neonatal period. All infants diagnosed after 20 weeks' gestation survived. Fetal hydrops developed in three fetuses, all of whom died. Inadequate ventilation secondary to prematurity was a contributing factor in each lethal case. Diagnosis at an early gestational age, development of fetal hydrops, and premature delivery predicted a poor prognosis. When possible, we recommend that delivery be delayed to allow for fetal development. Stabilization of the infant should be attempted before resection of the teratoma.


Subject(s)
Fetal Diseases/diagnostic imaging , Spinal Neoplasms/diagnostic imaging , Spinal Neoplasms/surgery , Teratoma/diagnostic imaging , Teratoma/surgery , Ultrasonography, Prenatal , Female , Fetal Diseases/therapy , Follow-Up Studies , Humans , Infant, Newborn , Male , Pregnancy , Retrospective Studies , Sacrococcygeal Region , Spinal Neoplasms/congenital , Spinal Neoplasms/mortality , Teratoma/congenital , Teratoma/mortality
17.
Am J Perinatol ; 15(8): 503-5, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9788651

ABSTRACT

Sacrococcygeal teratoma is the most common fetal neoplasm, with an incidence of 1 in 40,000 births. Fetuses with this malformation are at risk for significant perinatal morbidity and mortality. We identified nine fetuses with sacrococcygeal teratomas that were diagnosed antenatally and managed at the University of North Carolina Hospitals over a 7-year period. We reviewed retrospectively the charts of mothers and infants and recorded data concerning perinatal and surgical management. Six infants survived the neonatal period. All infants diagnosed after 20 weeks' gestation survived. Fetal hydrops developed in three fetuses, all of whom died. Inadequate ventilation secondary to prematurity was a contributing factor in each lethal case. Diagnosis at an early gestational age, development of fetal hydrops, and premature delivery predicted a poor prognosis. When possible, we recommend that delivery be delayed to allow for fetal development. Stabilization of the infant should be attempted before resection of the teratoma.


Subject(s)
Fetal Diseases/diagnostic imaging , Spinal Neoplasms/diagnostic imaging , Teratoma/diagnostic imaging , Ultrasonography, Prenatal , Female , Fetal Diseases/therapy , Follow-Up Studies , Humans , Hydrops Fetalis/etiology , Infant, Newborn , Male , Pregnancy , Retrospective Studies , Sacrococcygeal Region , Spinal Neoplasms/congenital , Spinal Neoplasms/mortality , Spinal Neoplasms/surgery , Teratoma/congenital , Teratoma/mortality
18.
Support Care Cancer ; 5(6): 504-5, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9406365

ABSTRACT

In cancer patients, hypersensitivity reactions to adjunctive medications are easily mistaken for cytostatic toxicities. We report on three patients with systemic reactions (flush, dyspnea, tachycardia, hypotension, back pain) to a lipid emulsion containing long chain fatty acids (LCT). Reexposure to LCT and exposure to MCT (medium chain fatty acids) solutions of slightly different composition--no soybean lecithin used as an emulsifier--were well tolerated. These data suggest that traces of soybean proteins are the allergenic agents. Therefore, hypersensitivity to concomitant medications, including parenteral nutrition, has to be considered in oncologic patients demonstrating severe systemic reactions to intravenous therapy.


Subject(s)
Drug Hypersensitivity/etiology , Fat Emulsions, Intravenous/adverse effects , Drug Hypersensitivity/diagnosis , Fat Emulsions, Intravenous/chemistry , Fatty Acids/analysis , Female , Humans , Male , Middle Aged , Neoplasms/therapy , Soybean Proteins/adverse effects , Soybean Proteins/analysis , Triglycerides/analysis
19.
Arch Virol ; 142(12): 2521-8, 1997.
Article in English | MEDLINE | ID: mdl-9672611

ABSTRACT

The sequence of the 300 nucleotides region of the measles virus genome was determined that includes a part of the 3'-untranslated region of the matrix (M) gene, the intergenic region and a part of the 5'-untranslated region of the fusion (F) gene [M-F region] for vaccine strain Leningrad-16 and 14 wild-type isolates. The data obtained demonstrate the variability of this long non-coding M-F region. No mutations in this region of the genome were found which seem to be specific for vaccine strains of measles virus (MV).


Subject(s)
Genome, Viral , Measles Vaccine/genetics , Measles virus/genetics , Viral Fusion Proteins/genetics , Viral Matrix Proteins/genetics , Animals , Base Sequence , Chlorocebus aethiops , DNA, Viral , Humans , Measles virus/classification , Molecular Sequence Data , Phylogeny , Sequence Homology, Nucleic Acid , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...